Recap: Cytokinetics Q2 Earnings

Recap: Cytokinetics Q2 Earnings

Cytokinetics CYTK reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Cytokinetics beat estimated earnings by 77.45%, reporting an EPS of $-0.23 versus an estimate of $-1.02.

Revenue was up $86.12 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.08 which was followed by a 1.68% drop in the share price the next day.

Here's a look at Cytokinetics's past performance:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.94 -0.84 -0.76 -0.65
EPS Actual -1.02 -0.36 -0.95 -0.86
Revenue Estimate 4.83M 6.20M 6.42M 5.45M
Revenue Actual 1.15M 55.60M 5.44M 2.84M

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.94 -0.84 -0.76 -0.65
EPS Actual -1.02 -0.36 -0.95 -0.86
Revenue Estimate 4.83M 6.20M 6.42M 5.45M
Revenue Actual 1.15M 55.60M 5.44M 2.84M

To track all earnings releases for Cytokinetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings